Molgen Biosciences Private Limited
Founded in 2019 and headquartered in Bihar, India.
2019 | Patna, Bihar (India) | Active
Molgen Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Molgen Biosciences
Molgen Biosciences Private Limited (MBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 29 October 2019 (Five years and four months 1 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Kumar and Abhishek Kumar serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304BR2019PTC043856
- Company No.
043856
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Food And Beverages
Textile
What products or services does Molgen Biosciences Private Limited offer?
Molgen Biosciences Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, IVDs & Analyzers, Biochemistry Analyzer, Hematology Analyzers, Diagnostic Medical Imaging Equipment, ECG Machine, Analyzers & Analytical Instruments, Elemental Analyzer.
Who are the key members and board of directors at Molgen Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Kumar  | Director | 29-Oct-2019 | Current |
| Abhishek Kumar | Director | 29-Oct-2019 | Current |
Financial Performance of Molgen Biosciences.
Enhance accessibility to Molgen Biosciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Molgen Biosciences?
Unlock access to Molgen Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Molgen Biosciences?
Unlock and access historical data on people associated with Molgen Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Molgen Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molgen Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.